149 related articles for article (PubMed ID: 2468003)
1. [Activity of 2, 5-oligoadenylate synthetase in non-A, non-B hepatitis].
Karino Y; Sugawara T; Saga A; Matsushima T; Miyazaki T
Nihon Rinsho; 1988 Dec; 46(12):2715-9. PubMed ID: 2468003
[No Abstract] [Full Text] [Related]
2. Changes in 2',5'-oligoadenylate synthetase activity in peripheral blood mononuclear cells from patients with fulminant hepatitis.
Nishino S; Ohnishi H; Muto Y; Moriwaki H; Sakai T; Sugihara J; Saitoh K
Gastroenterol Jpn; 1989 Jun; 24(3):337. PubMed ID: 2744346
[No Abstract] [Full Text] [Related]
3. Detection of 2',5' oligoadenylate synthetase activity in acute viral hepatitis with special reference to histologic features in the acute stage.
Okuno T; Shindo M; Arai K; Matsumoto M; Takeda M; Kashima K; Sokawa Y
Gastroenterol Jpn; 1991 Apr; 26(2):162-9. PubMed ID: 1710193
[TBL] [Abstract][Full Text] [Related]
4. Methods for the determination of the interferon-induced enzyme 2'-5' oligoadenylate synthetase in mononuclear blood cells.
Bruchelt G; Beck J; Schilbach-Stückle K; Koscielniak E; Treuner J; Niethammer D
J Clin Chem Clin Biochem; 1987 Dec; 25(12):879-88. PubMed ID: 2450958
[TBL] [Abstract][Full Text] [Related]
5. 2',5'-Oligoadenylate synthetase activity in the liver and peripheral blood mononuclear cells of chronic hepatitis patients.
Ogawa Y
Gastroenterol Jpn; 1988 Jun; 23(3):279-86. PubMed ID: 2456963
[TBL] [Abstract][Full Text] [Related]
6. [Changes of serum 2',5'-oligoadenylate synthetase activity and neopterin during interferon treatment for chronic hepatitis C].
Daito K; Suou T; Kawasaki H
Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):981-5. PubMed ID: 7563914
[No Abstract] [Full Text] [Related]
7. Serum 2',5'-oligoadenylate synthetase activity during interferon treatment of chronic hepatitis B.
Shindo M; Okuno T; Matsumoto M; Takeda M; Takino T; Sokawa J; Iwata A; Sokawa Y
Hepatology; 1988; 8(2):366-70. PubMed ID: 2451634
[TBL] [Abstract][Full Text] [Related]
8. Study of 2'5' oligo (A) synthetase in patients with metastatic renal cell carcinoma.
Vakalikos J; Dimasis N; Peftulidis S; Galaktidou G; Kortsaris AH
Int J Biol Markers; 1995; 10(2):113-4. PubMed ID: 7561235
[No Abstract] [Full Text] [Related]
9. 2'5' Oligoadenylate synthetase assay in human diseases. Its clinical value in viral liver diseases.
Chousterman S; Chousterman M; Poitrine A; Chaput JC; Thang MN
Prog Clin Biol Res; 1985; 202():431-8. PubMed ID: 3008173
[No Abstract] [Full Text] [Related]
10. Elevated levels of 2',5'-oligoadenylate synthetase activity in peripheral blood mononuclear cells and serum during acute exacerbation of chronic hepatitis B.
Shindo M; Okuno T; Arai K; Matsumoto M; Takeda M; Takino T; Sokawa Y
Hepatology; 1989 May; 9(5):715-9. PubMed ID: 2468593
[TBL] [Abstract][Full Text] [Related]
11. Activity of the interferon-induced 2',5'-oligoadenylate synthetase in patients with chronic hepatitis C.
Pawlotsky JM; Hovanessian A; Roudot-Thoraval F; Lebon P; Robert N; Bouvier M; Babany G; Duval J; Dhumeaux D
J Interferon Cytokine Res; 1995 Oct; 15(10):857-62. PubMed ID: 8564707
[TBL] [Abstract][Full Text] [Related]
12. [2' 5'-oligoadenylate synthetase (2-5AS)].
Kaneko S; Sakai A
Nihon Rinsho; 2004 Dec; 62 Suppl 12():812-4. PubMed ID: 15658457
[No Abstract] [Full Text] [Related]
13. [The effect of different types of recombinant interferon on the induction of 2,5-oligoadenylate synthetase in natural killers and the tumor cells in bladder cancer patients].
Vozianov AF; Drannik GN; Verkhatskaia AA; Zavelevich MP; Prokhnevskaia EL; Verkhatskiĭ PP; Klimenko IA
Urol Nefrol (Mosk); 1993; (5):22-5. PubMed ID: 7508649
[TBL] [Abstract][Full Text] [Related]
14. Induction of intracellular and plasma 2',5'-oligoadenylate synthetase by pentostatin.
Ho AD; Klotzbücher A; Gross A; Dietz G; Mestan J; Jakobsen H; Hunstein W
Leukemia; 1992 Mar; 6(3):209-14. PubMed ID: 1564958
[TBL] [Abstract][Full Text] [Related]
15. Interferon and 2',5'-oligo(A) synthetase activities in serum and blood mononuclear leukocytes of cattle after injection of bovine interferon-alpha 1.
Perino LJ; Short EC; Burge LJ; Winter DA; Fulton RW
Am J Vet Res; 1990 Jun; 51(6):886-92. PubMed ID: 1695068
[TBL] [Abstract][Full Text] [Related]
16. [Investigation of 2'-5' oligoadenylate synthetase activity in peripheral blood mononuclear leukocytes in Behçet's disease].
Ohno S; Kotake S; Hirose S; Matsuda H; Fujii N
Nippon Ganka Gakkai Zasshi; 1986 May; 90(5):771-4. PubMed ID: 2428227
[No Abstract] [Full Text] [Related]
17. Clinical value of the determination of an interferon-induced enzyme activity: studies of the 2'5' oligoadenylate synthetase activity in peripheral blood lymphocytes of patients.
Chousterman S; Chousterman M; Reinert P; Thang MN
Biomed Pharmacother; 1983; 37(4):176-80. PubMed ID: 6198003
[TBL] [Abstract][Full Text] [Related]
18. Serum 2',5'-oligoadenylate synthetase concentrations in acute and chronic hepatitis C.
Yang PM; Wang JT; Chiang BL; Lai MY; Chen DS
J Formos Med Assoc; 1997 May; 96(5):314-9. PubMed ID: 9170817
[TBL] [Abstract][Full Text] [Related]
19. Effect of alpha interferon (IFN-alpha) on 2'-5' oligoadenylate synthetase activity in peripheral blood mononuclear cells of patients with chronic hepatitis C: relationship to the antiviral effect of IFN-alpha.
Pawlotsky JM; Hovanessian AG; Roudot-Thoraval F; Robert N; Bouvier M; Babany G; Duval J; Dhumeaux D
Antimicrob Agents Chemother; 1996 Feb; 40(2):320-4. PubMed ID: 8834873
[TBL] [Abstract][Full Text] [Related]
20. [Non-specific immune response in acute viral hepatitis: studies from serum 2,5-oligoadenylate synthetase activity and serum and histochemical changes in beta 2 microglobulin].
Suzuki H
Nihon Shokakibyo Gakkai Zasshi; 1988 Aug; 85(8):1508-17. PubMed ID: 3054207
[No Abstract] [Full Text] [Related]
[Next] [New Search]
